HT
EW icon

Headlands Technologies’s Edwards Lifesciences EW Stock Holding History

Headlands Technologies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$945K Buy
+10,451
New +$875K 0.1% 251
2025
Q3 		– Sell
-398
Closed -$31.1K – 831
2025
Q2 		$31.1K Sell
398
-270
-40% -$20.1K ﹤0.01% 862
2025
Q1 		$48.4K Buy
+668
New +$47.8K 0.01% 717
2024
Q4 		– Sell
-15,384
Closed -$1.02M – 1305
2024
Q3 		$1.02M Buy
+15,384
New +$1.12M 0.12% 191
2024
Q1 		– Sell
-5,362
Closed -$409K – 1325
2023
Q4 		$409K Buy
5,362
+2,873
+115% +$200K 0.12% 159
2023
Q3 		$172K Sell
2,489
-6,795
-73% -$546K 0.08% 224
2023
Q2 		$876K Buy
+9,284
New +$807K 0.28% 87
2023
Q1 		– Sell
-129
Closed -$10K – 568
2022
Q4 		$10K Buy
+129
New +$9.94K 0.01% 357

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Headlands Technologies's EW Position: Q2 2026 in Review

Headlands Technologies opened a new position in Edwards Lifesciences (EW) in Q2 2026: 10,451 shares worth $945K. The stake represents 0.1% of the portfolio and ranks #251 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in EW as recently as Q2 2025.

Headlands Technologies first reported a position in EW in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.02M in Q3 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Headlands Technologies held 10,451 shares of Edwards Lifesciences worth $945K as of Q2 2026.
  • Edwards Lifesciences was a new Headlands Technologies position in Q2 2026.
  • Edwards Lifesciences made up 0.1% of Headlands Technologies's portfolio in Q2 2026, its #251 holding.
  • Headlands Technologies first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 8 quarters since.
  • Headlands Technologies's Edwards Lifesciences position peaked at $1.02M in Q3 2024.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.